628
H. M. GENC¸ KAL ET AL.
X
X
HN1
H2N
O
2
3
N
H
+
-H2O
H2N
H
N
H
N
OH
OH
HLn
carbonyl oxime
2-ABA
X=Cl for 3-ClINAP and n:1
or Br for 3-BrINAP and n:2
SCH. 1. Synthesis of the HLn.
Magnetic susceptibility measurements were performed at room was filtered, washed with cold ethanol and finally dried on air
temperature with a Sherwood Scientific MK1 model Magnetic (Scheme 1).
Susceptibility Balance.
2-(3-Chloro-Phenyl)-1,2,3,4-Tetrahydro-Quinazoline-2-
Carbaldehyde Oxime, (HL1). Yield: 0.87 g, 60.4% (white
crystals). m.p.: 158◦C (DTAmax, decomposition point). Anal.
Calcd. for C15H14N3OCl (287.75 g mol−1) (%): C, 62.61; H,
4.90; N, 14.60. Found: C, 62.18; H, 4.57; N, 14.60. FT-IR (KBr
pellet, ν cm−1): 3406, 3263 (s, sh, N H); 2963 (H C N);
2764 (b, N····H O ); 1607 (sh, C Noxime); 944 (s, sh, N O).
1H NMR (DMSO-d6, δ ppm J Hz): 10.94 (s, OH, 1H); 7.58
Preparation of the ␣-Carbonyl Oximes
α-Carbonyl oximes were prepared according to a literature
method[23] with little modification. Nitrosation of 1-(3-chloro-
phenyl)-ethanone or 1-(3-bromo-phenyl)-ethanone with butyl
nitrite afforded the corresponding α-carbonyl oximes. Struc-
tures of the α-carbonyl oximes were inferred from its FT-IR and
NMR spectral data.
(t, J = 1.6, Haromatic, 1H); 7.52 (dt, J = 8.0; 1.2, Haromatic
,
(3-Chloro-Phenyl)-Oxo-Acetaldehyde Oxime, (3-ClINAP).
FT-IR (KBr pellet, ν cm−1): 3244 (s, O H); 2985 (w, H C N);
1628 (s, sh, C-O); 1573 (sh, C Noxime); 1003 (s, sh, N O).
1H NMR (DMSO-d6, δ ppm J Hz): 12.85 (s, OH, 1H); 7.99 (s,
HC N, 1H); 7.97 (s, Haromatic, 1H), 7.89–7.86 (m, Haromatic, 1H),
1H); 7.44 (s, HC N, 1H); 7.35 (t, J = 7.8, Haromatic, 1H);
7.31–7.28 (m, Haromatic, 1H); 6.92 (t, J = 7.6, Haromatic, 1H);
6.73 (d, J = 7.8, Haromatic, 2H); 6.78 (s, N1H, 1H); 6.47 (dt, J
= 7.4, 1.2, Haromatic, 1H); 3.70 (dd, J = 16.8, 5.6, CH2 N,
1H); 3.46–3.40 (m, CH2 N, 1H); 3.31–3.24 (m, N3H, 1H).
13C NMR (DMSO-d6, δ ppm): 152.44 (C Noxime); 146.53,
143.04, 133.22, 130.42, 127.86, 127.67, 127.23, 126.61,
125.97, 120.29, 116.58, 114.75 (Caromatic); 70.93 (Ph>C<);
41.93 ( CH2 N). m/z: 287.6 [HL1]+.
7.72–7.70 (m, Haromatic, 1H), 7.55 (t, J = 8, Haromatic, 1H). 13
C
NMR (DMSO-d6, δ ppm): 188.40 (C O); 148.27 (C Noxime);
138.31, 133.51, 133.21, 130.87, 129.86, 128.61 (Caromatic).
(3-Bromo-Phenyl)-Oxo-Acetaldehyde Oxime, (3-BrINAP).
FT-IR (KBr pellet, ν cm−1): 3253 (s, O H); 3003 (w, H C N);
1642 (s, sh, C O); 1565 (sh, C Noxime); 998 (s, sh, N O).
1H NMR (DMSO-d6, δ ppm J Hz): 12.84 (s, OH, 1H); 7.98 (s,
HC N, 1H); 8.10 (s, Haromatic, 1H), 7.92–7.90 (m, Haromatic, 1H),
2-(3-Bromo-Phenyl)-1,2,3,4-Tetrahydro-Quinazoline-2-
Carbaldehyde oxime, (HL2). Yield: 0.98 g, 59.0% (white
crystals). m.p.: 159◦C (DTAmax, decomposition point). Anal.
Calcd. for C15H14N3OBr (332.20 g mol−1) (%): C, 54.23; H,
4.25; N, 12.65. Found: C, 53.95; H, 3.84; N, 12.31. FT-IR (KBr
pellet, ν cm−1): 3408, 3264 (s, sh, N H); 2962 (H C N);
2765 (b, N····H O ); 1606 (sh, C Noxime); 943 (s, sh, N O).
1H NMR (DMSO-d6, δ ppm, J Hz): 10.95 (s, OH, 1H); 7.72
(t, J = 1.6, Haromatic, 1H); 7.56 (d, J = 1.6, Haromatic, 1H);
7.44 (s, HC N, 1H); 7.42 (d, J = 3.2, Haromatic, 1H); 7.29 (t,
J = 7.8, Haromatic, 1H); 6.92 (t, J = 7.8, Haromatic, 1H); 6.80
(s, N1H, 1H); 6.73 (t, J = 8, Haromatic, 2H); 6.46 (dt, J = 7.2,
1.2, Haromatic, 1H); 3.70 (dd, J = 16.8, 5.6, CH2 N, 1H);
3.46–3.40 (m, CH2 N, 1H); 3.29–3.25 (m, N3H, 1H). 13C
NMR (DMSO-d6, δ ppm): 152.47 (C Noxime); 146.76, 143.02,
130.73, 130.55, 127.24, 127.00, 125.97, 121.89, 120.28,
7.85–7.82 (m, Haromatic, 1H), 7.48 (t, J = 8, Haromatic, 1H). 13
C
NMR (DMSO-d6, δ ppm): 188.33 (C O); 148.29 (C Noxime);
138.51, 136.09, 132.73, 131.11, 128.96, 121.93 (Caromatic).
Preparation of the Ligands
HL1 and HL2 were prepared by the usual condensa-
tion method. A solution of 2-aminobenzylamine (2-ABA)
(5.00 mmol, 0.61 g) in 5 mL of absolute ethanol was added
dropwise to a solution of 3-ClINAP (5.00 mmol, 0.92 g) or 3-
BrINAP (5.00 mmol, 1.15 g) in 15 mL of absolute ethanol. The
reaction mixture was stirred for 2 h at room temperature and
left for a few days at room temperature. The reaction product